Patent · US Active

Inhibitors of CXCR2

US11040960B2 · kind B2 · utility

3Cited by

5References

14Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Xi Chen · Beijing, CN
Dean R. Dragoli · Los Altos, US
Junfa Fan · Palo Alto, US
Jaroslaw Kalisiak · Newark, US
Manmohan Reddy Leleti · Sunnyvale, US
Viengkham Malathong · Mountain View, US
Jeffrey P. McMahon · San Francisco, US
Hiroko Tanaka · Foster City, US
Ju Yang · Palo Alto, US
Chao YU · Sunnyvale, US
Penglie Zhang · Foster City, US
Venkat Reddy Mali · Cupertino, US

Key dates

Filing date	Jun 12, 2019
Grant date	Jun 22, 2021
Priority date	—
Expiry date	Jun 12, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds are provided as inhibitors of CXCR2, having the structure:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.